Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New breast cancer research reported from University of Texas
April 17th, 2008
"Many chemotherapeutic and biologic agents used for advanced breast cancer exhibit activity alone or in combination, but the small number of randomized trials, coupled with the significant heterogeneity of patient and tumor characteristics, have precluded the development of standardized, evidence-based approaches to therapy for advanced disease. This expert faculty roundtable discussion focused on chemotherapy regimens used in pretreated patients," scientists writing in the journal Clinical Breast Cancer report. "Given the increasing data on taxanes in this setting, a specific need was identified that led to the theme of standard and novel taxanes in this...
Source: Women's Health Weekly (2008-04-17)
|
